Showing results (81-90 of 203) with videos related to
Sort By:
Pageof 21
Cancer|August 8, 2013
Cost effectiveness of alternative strategies for incorporating bevacizumab into the primary treatment of ovarian cancerJason C Barnett, Angeles Alvarez Secord, David E Cohn, et al.Sexually Transmitted Diseases|May 15, 2014
Impact of a routine, opt-out HIV testing program on HIV testing and case detection in North Carolina sexually transmitted disease clinicsPamela W Klein, Lynne C Messer, Evan R Myers, et al.Obstetrics and Gynecology|July 5, 2005
Prospective data collection of a new procedure by a specialty society: the FIBROID registryEvan R Myers, Scott Goodwin, Wendy Landow, et al.Gynecologic Oncology|February 17, 2009
Determination of quality of life-related utilities for health states relevant to ovarian cancer diagnosis and treatmentLaura J Havrilesky, Gloria Broadwater, Debra M Davis, et al.Gynecologic Oncology|September 1, 2020
Cost-effectiveness analysis comparing "PARP inhibitors-for-all" to the biomarker-directed use of PARP inhibitor maintenance therapy for newly diagnosed advanced stage ovarian cancerRafael Gonzalez, Laura J Havrilesky, Evan R Myers, et al.Journal of Women'S Health (2002)|May 19, 2009
A prospective study of weight gain after premenopausal hysterectomyPatricia G Moorman, Joellen M Schildkraut, Edwin S Iversen, et al.Obstetrics and Gynecology|May 2, 2006
Cost-effectiveness analysis of liquid-based cytology and human papillomavirus testing in cervical cancer screeningMichael A Bidus, G Larry Maxwell, Shalini Kulasingam, et al.Cancer|January 22, 2011
Development of an ovarian cancer screening decision model that incorporates disease heterogeneity: implications for potential mortality reductionLaura J Havrilesky, Gillian D Sanders, Shalini Kulasingam, et al.American Journal of Obstetrics and Gynecology|June 9, 2023
Maternal morbidity and mortality among patients with cancer at time of deliveryAlexandra C Sundermann, Jennifer M Cate, Alexa K Campbell, et al.BJOG : an International Journal of Obstetrics and Gynaecology|May 3, 2023
Geographic variation in the rate and route of hysterectomy for benign disease in the USA: A retrospective cross-sectional studyBenjamin B Albright, Quetrell D Heyward, Alaattin Erkanli, et al.Pageof 21